Uma Saxena
Safdarjang Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Uma Saxena.
International Journal of Dermatology | 1993
Venkatesa Ramesh; R. S. Misra; Uma Saxena; A. Mukherjee
Background. Post‐kala‐azar dermal leishmaniasis is a condition peculiarly confined to the Indian subcontinent.
Clinical and Experimental Dermatology | 1991
V. Ramesh; R. S. Misra; Uma Saxena; A. Mukherjee
Three antituberculous drug regimens have been employed to study the therapeutic response in 90 patients with any one of the commonly encountered paucibacillary forms of skin tuberculosis, namely lupus vulgaris, tuberculosis verrucosa cutis and scrofuloderma. The first two regimens contained rifampicin, isoniazid and either pyrazinamide or thiacetazone, and the third regimen had rifampicin and isoniazid only. The disease was clinically defined as localized when confined to one area and widespread when the lesions were disseminated. The observations revealed that the response of lupus vulgaris and tuberculosis verrucosa cutis was alike in all the three regimens, with the localized lesions subsiding completely after 4 months of therapy and the more extensive forms taking 5 months. Patients with scrofuloderma responded similarly to both the triple drug regimens. The discharge, sinuses and ulcers cleared in 6 months but the lymph nodes took longer to regress, up to 7 months in localized and 9 months in more widespread scrofuloderma. To obtain the same results with rifampicin and isoniazid, all patients with widespread scrofuloderma and one‐third of those with localized forms had to be treated for 10 and 9 months, respectively. No serious drug side‐effects, apart from giddiness with rifampicin and acneiform eruptions with thiacetazone, were encountered. No instances of relapse were noted in the 50% of patients who were followed‐up for 31/2 years after therapy. Single‐drug therapy with isoniazid for lupus vulgaris, as given in the past, is to be discouraged as it may promote the emergence of drug‐resistant bacilli in those with an undetected focus of infection. An additional object of defining effective mutliple drug regimens is to improve patient compliance by reducing the duration of therapy and to avoid confusion by adhering uniformly to the recommended regimen in places where tuberculosis is prevalent.
Clinical and Experimental Dermatology | 1990
Uma Saxena; V. Ramesh; R. S. Misra; A. Mukherjee
Two leprosy patients with neuritis caused by giant abscesses involving almost the entire ulnar nerve are described. One patient, who also had skin lesions, was diagnosed histopathologically as having borderline tuberculoid leprosy both on skin and nerve biopsy, and the other, with only nerve involvement, belonged to the pure neuritic group. The lepromin test was strongly positive (with a vesicular reaction in one patient) and lymphocyte transformation to Mycobacterium leprae antigen was raised. These lesions can be easily mistaken for a peripheral nerve tumour in places where leprosy is uncommon. A brief account of the management of nerve abscess in leprosy is given.
International Journal of Dermatology | 1993
Uma Saxena; R. S. Misra; V. Ramesh
Background. When multidrug therapy was introduced a decade ago to shorten the duration of treatment, paucibacillary leprosy was advocated 6 months of treatment. The diagnosis is based mainly on clinical and histopathologic examination, negative slit‐skin smear examination, and positive lepromin test.
International Journal of Dermatology | 1990
Uma Saxena; V. Ramesh; R. S. Misra; A. Mukherjee
ABSTRACT: Ten patients with fully treated pauchibacillary leprosy, mainly tuberculoid, had asymptomatic nodules present along the peripheral nerves that persisted even after the skin lesions had completely subsided and treatment was stopped. Histopathology of the nodules revealed no signs of activity of the disease. The evolution, follow‐up care, and significance of these nodules are discussed.
Leprosy Review | 1991
Uma Saxena; V. Ramesh; R. S. Misra; A. Mukherjee
Three patients of histopathologically confirmed borderline-tuberculoid leprosy showing no acid-fast bacilli and with lesions confined to the face, 2 on the cheek and 1 on the forehead, were given multidrug therapy as recommended by the WHO for paucibacillary cases. Within 3 months the lesions showed signs of upgrading (or reversal) reaction which was substantiated by histopathology. In 1 patient the facial nerve was affected leading to facial palsy. The lymphocyte transformation test did not show a significant rise. All 3 patients were given oral prednisolone for periods varying between 5 and 7 months, but the response was poor except in 1 patient in whom the facial palsy responded favourably. Injections of sodium antimony gluconate tried in 1 patient after stoppage of steroids did not control the reaction. After 18 months of regular follow-up during therapy, the cutaneous reaction in the patient with facial nerve involvement subsided leaving significant atrophy. However, in the other 2 patients the skin lesion persisted with clinical and histopathological evidence of upgrading reaction. The reasons for the unnatural persistence of reaction in these patients is not clear.
Leprosy Review | 1990
Uma Saxena; S. Ravi; V. Ramesh; R. S. Misra; Ashok Mukherjee
A case of healed tuberculoid leprosy (TT) with multiple superficial nerve abscesses involving the whole cutaneous network on the patch is reported. To the best of our knowledge multiple cutaneous nerve abscesses involving the entire subcutaneous plexus on a TT patch is a very uncommon observation.
Dermatology | 1991
Uma Saxena; V. Ramesh; R. S. Misra
Archives of Dermatology | 1992
Ramesh; Uma Saxena; A. Mukherjee; R. S. Misra
Archives of Dermatology | 1992
V. Ramesh; Uma Saxena; A. Mukherjee; R. S. Misra